Tilray Inc. (NASDAQ:TLRY) shares traded higher over the last trading session, gaining 8.83% on 05/17/21. The shares fell to a low of $13.69 before closing at $15.16. Intraday shares traded counted 23.97 million, which was 2.67% higher than its 30-day average trading volume of 24.63M. TLRY’s previous close was $13.93 while the outstanding shares total 316.80M. The stock’s Relative Strength Index (RSI) is 42.77, with weekly volatility at 10.13% and ATR at 1.53. The TLRY stock’s 52-week price range has touched low of $4.41 and a $67.00 high.
Investors have identified the Drug Manufacturers – Specialty & Generic company Tilray Inc. as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $6.66 billion, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
Tilray Inc. (TLRY) Fundamentals that are to be considered.
When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. In terms of their assets, the company currently has 571.97 million total, with 283.99 million as their total liabilities.
Is the stock of TLRY attractive?
In related news, Chief Financial Officer, Merton Carl A sold 89,000 shares of the company’s stock in a transaction that recorded on May 12. The sale was performed at an average price of 14.82, for a total value of 1,318,980. As the sale deal closes, the Director, St.Clare Christine now sold 2,200 shares of the company’s stock, valued at 22,000. Also, President and CEO, Kennedy Brendan sold 400,000 shares of the company’s stock in a deal that was recorded on Nov 06. The shares were price at an average price of 9.88 per share, with a total market value of 3,953,291. Following this completion of acquisition, the Director, St.Clare Christine now holds 4,400 shares of the company’s stock, valued at 44,233. In the last 6 months, insiders have changed their ownership in shares of company stock by 2.40%.
4 out of 18 analysts covering the stock have rated it a Buy, while 13 have maintained a Hold recommendation on Tilray Inc.. 1 analysts has assigned a Sell rating on the TLRY stock. The 12-month mean consensus price target for the company’s shares has been set at $18.73.